AiCure Funding & Investors
AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments. It enables intelligent decision-making and improving health outcomes. It has developed patented facial recognition and motion-sensing technology to confirm medication ingestion in real-time. AiCure's platform has the potential to revolutionize the cost-effectiveness of healthcare delivery systems by enhancing treatment and reducing risks. Their software captures and understands video, audio, and behavioral data to establish the link between patients, disease, and treatment. It was founded in 2010 and is headquartered in New York.
aicure.comTotal Amount Raised: $68,750,000
AiCure Funding Rounds
Grant
$1,000,000
Grant Investors
National Institute on Drug Abuse (NIDA)Series Unknown
$4,000,000
Debt Financing
$12,000,000
Series C
$24,500,000
Series C Investors
Palisades Growth CapitalBaird CapitalTribeca Venture PartnersPritzker Group Venture CapitalAccelmedBiomatics Capital PartnersFirst Citizens BankAsahi KaseiSpringRock VenturesNew Leaf Venture PartnersSingtel Innov8Series B
$15,000,000
Series B Investors
Baird CapitalNew Leaf Venture PartnersPritzker Group Venture CapitalTribeca Venture PartnersBiomatics Capital PartnersSeries A
$12,250,000
Series A Investors
New Leaf Venture PartnersPritzker Group Venture CapitalTribeca Venture PartnersBiomatics Capital Partners